GT BIOPHARMA INC (GTBP:NASDAQ)
$0.369 -0.0213 (-5.4573%)
Analysed GT BIOPHARMA INC (GTBP:NASDAQ) News Sources
RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation
10-04-2026
yahoo.com
GT Biopharma (GTBP) Upgraded to Buy: Here's What You Should Know
16-03-2026
yahoo.com
GT Biopharma (GTBP) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
12-03-2026
yahoo.com
GT Biopharma to Participate in the 38th Annual Roth Conference
11-03-2026
yahoo.com
GT Biopharma Reports Full Year 2025 Financial Results
02-03-2026
yahoo.com
GT Biopharma to Present at the Centurion One Capital 9th Annual Toronto Growth Conference
17-02-2026
yahoo.com
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-5550 TriKE®, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors Expressing B7-H3
03-02-2026
yahoo.com
GT Biopharma Announces IND Submission for GTB-5550 TriKE®, a B7-H3-targeted natural killer (NK) cell engager for B7-H3 expressing solid tumor cancers
15-01-2026
yahoo.com
Stocks & Markets Podcast: Biotech CEO reveals the science of humane cancer treatment
08-12-2025
thestreet.com
GT Biopharma, Inc. (NASDAQ:GTBP) Offers Near-Term Catalyst Opportunity with Advancing Phase 1 Trials
19-11-2025
yahoo.com
What is the current price of GT BIOPHARMA INC (GTBP:NASDAQ)?
The current price of GT BIOPHARMA INC (GTBP:NASDAQ) is $0.369.
GT BIOPHARMA INC (GTBP:NASDAQ) absolute price change since previous trading day?
The absolute price change of GT BIOPHARMA INC (GTBP:NASDAQ) since the previous trading day is $-0.0213.
GT BIOPHARMA INC (GTBP:NASDAQ) percentage price change since previous trading day?
The percentage price change of GT BIOPHARMA INC (GTBP:NASDAQ) since the previous trading day is -5.4573%.
What is the most recent average sentiment score for GT BIOPHARMA INC (GTBP:NASDAQ)?
The most recent average sentiment score for GT BIOPHARMA INC (GTBP:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for GT BIOPHARMA INC (GTBP:NASDAQ)?
The most recent sentiment for GT BIOPHARMA INC (GTBP:NASDAQ) is .
SEC-8K** Filing Available For GT BIOPHARMA INC (GTBP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.